Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Photo: Kerem Yucel/AFP via Getty Images
The Centers for Medicare & Medicaid Services announced yesterday that it's launching a new voluntary model that would allow seniors to buy insulin with no more than a $35 monthly copay.
Why it matters: Medicare beneficiaries who rely on insulin and are enrolled in a participating plan would save an average of $446 a year in out-of-pocket costs. This move may not target the overall price of insulin, but it could meaningfully lower what seniors pay themselves for it.
Go deeper: Insulin prices propel higher spending among diabetics